Procept Capital Surpluse from 2010 to 2024
| PRCT Stock | USD 95.59 1.70 1.75% |
Capital Surpluse | First Reported 2010-12-31 | Previous Quarter 475.8 M | Current Value 422.9 M | Quarterly Volatility 29.6 M |
Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 1.9 M, Interest Income of 5.8 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 13.81, Dividend Yield of 0.0 or PTB Ratio of 7.41. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
Procept | Capital Surpluse |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.